Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

32 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Bendamustine is effective in T-cell prolymphocytic leukaemia.
Herbaux C, Genet P, Bouabdallah K, Pignon JM, Debarri H, Guidez S, Betrian S, Leleu X, Facon T, Morschhauser F, Damaj G, Cazin B, Ysebaert L. Herbaux C, et al. Among authors: betrian s. Br J Haematol. 2015 Mar;168(6):916-9. doi: 10.1111/bjh.13175. Epub 2014 Oct 15. Br J Haematol. 2015. PMID: 25316212 Free article. No abstract available.
Impact of pattern of recurrence on post-relapse survival according to surgical timing in patients with advanced ovarian cancer.
Angeles MA, Spagnolo E, Cabarrou B, Pérez-Benavente A, Gil Moreno A, Guyon F, Rychlik A, Migliorelli F, Bataillon G, Navarro AS, Betrian S, Ferron G, Hernández A, Martinez A. Angeles MA, et al. Among authors: betrian s. Int J Gynecol Cancer. 2023 Jan 3;33(1):50-56. doi: 10.1136/ijgc-2022-003985. Int J Gynecol Cancer. 2023. PMID: 36446410
[Chronic lymphoid leukaemia].
Bétrian S, Ysebaert L. Bétrian S, et al. Rev Prat. 2013 Jan;63(1):113-7. Rev Prat. 2013. PMID: 23457842 Review. French. No abstract available.
Antiangiogenic effects in patients with progressive desmoplastic small round cell tumor: data from the French national registry dedicated to the use of off-labeled targeted therapy in sarcoma (OUTC's).
Bétrian S, Bergeron C, Blay JY, Bompas E, Cassier PA, Chevallier L, Fayette J, Girodet M, Guillemet C, Le Cesne A, Marec-Berard P, Ray-Coquard I, Chevreau C. Bétrian S, et al. Clin Sarcoma Res. 2017 May 10;7:10. doi: 10.1186/s13569-017-0076-4. eCollection 2017. Clin Sarcoma Res. 2017. PMID: 28491276 Free PMC article.
Effect of tumor burden and radical surgery on survival difference between upfront, early interval or delayed cytoreductive surgery in ovarian cancer.
Angeles MA, Cabarrou B, Gil-Moreno A, Pérez-Benavente A, Spagnolo E, Rychlik A, Martínez-Gómez C, Guyon F, Zapardiel I, Querleu D, Illac C, Migliorelli F, Bétrian S, Ferron G, Hernández A, Martinez A. Angeles MA, et al. Among authors: betrian s. J Gynecol Oncol. 2021 Nov;32(6):e78. doi: 10.3802/jgo.2021.32.e78. Epub 2021 Aug 13. J Gynecol Oncol. 2021. PMID: 34431252 Free PMC article.
32 results